Delayed contralateral hemiplegia following herpes zoster ophthalmicus: should antiviral therapy be used?
We review clinical virological studies in the syndrome of delayed contralateral hemiplegia following herpes zoster ophthalmicus. Virus could not be isolated from the cerebrospinal fluid (CSF) of the present case, nor was antiviral antibody found in the CSF. There appear to have been no reports of successful virus isolation from the CSF although there are reports of antibody in the spinal fluid. Thus the evidence for ongoing viral replication in the central nervous system is marginal. It is suggested that the sensitive antibody assay against membrane antigens (FAMA) be used in the future as a guide to antiviral therapy.
Booss
J
J
Haak
B B
BB
Leroy
R F
RF
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002536:Cerebral Arteries / Q000382:microbiology; D006429:Hemiplegia / Q000188:drug therapy* / Q000382:microbiology; D006563:Herpes Zoster Ophthalmicus / Q000188:drug therapy* / Q000382:microbiology; D014645:Herpesvirus 3, Human / Q000302:isolation & purification; D006801:Humans; D008297:Male; D013577:Syndrome; D012668:Trigeminal Ganglion / Q000382:microbiology; D014740:Vidarabine / Q000627:therapeutic use*
D000914:Antibodies, Viral; D014740:Vidarabine